Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
J Vet Pharmacol Ther ; 37(4): 317-24, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24495176

ABSTRACT

Janus kinase (JAK) enzymes are involved in cell signaling pathways activated by various cytokines dysregulated in allergy. The objective of this study was to determine whether the novel JAK inhibitor oclacitinib could reduce the activity of cytokines implicated in canine allergic skin disease. Using isolated enzyme systems and in vitro human or canine cell models, potency and selectivity of oclacitinib was determined against JAK family members and cytokines that trigger JAK activation in cells. Oclacitinib inhibited JAK family members by 50% at concentrations (IC50 's) ranging from 10 to 99 nm and did not inhibit a panel of 38 non-JAK kinases (IC50 's > 1000 nM). Oclacitinib was most potent at inhibiting JAK1 (IC50 = 10 nM). Oclacitinib also inhibited the function of JAK1-dependent cytokines involved in allergy and inflammation (IL-2, IL-4, IL-6, and IL-13) as well as pruritus (IL-31) at IC50 's ranging from 36 to 249 nM. Oclacitinib had minimal effects on cytokines that did not activate the JAK1 enzyme in cells (erythropoietin, granulocyte/macrophage colony-stimulating factor, IL-12, IL-23; IC50 's > 1000 nM). These results demonstrate that oclacitinib is a targeted therapy that selectively inhibits JAK1-dependent cytokines involved in allergy, inflammation, and pruritus and suggests these are the mechanisms by which oclacitinib effectively controls clinical signs associated with allergic skin disease in dogs.


Subject(s)
Cytokines/antagonists & inhibitors , Dermatologic Agents/pharmacology , Dogs/blood , Enzymes/blood , Janus Kinases/antagonists & inhibitors , Pyrimidines/pharmacology , Sulfonamides/pharmacology , Animals , Cytokines/genetics , Cytokines/metabolism , Dermatologic Agents/chemistry , Gene Expression Regulation/drug effects , Humans , Molecular Structure , Pyrimidines/chemistry , Sulfonamides/chemistry
2.
Int J Parasitol ; 33(2): 199-208, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12633657

ABSTRACT

KHEYLRF-NH(2) (AF2) is a FMRFamide-related peptide (FaRP) present in parasitic and free-living nematodes. At concentrations as low as 10 pM, AF2 induces a biphasic tension response, consisting of a transient relaxation followed by profound excitation, in neuromuscular strips prepared from Ascaris suum. In the present study, the effects of AF2 on cyclic adenosine monophosphate (cAMP), cyclic guanosine monophosphate (cGMP) and inositol-1,4,5-triphosphate (IP(3)) levels were measured following muscle tension recordings from 2 cm neuromuscular strips prepared from adult A. suum. AF2 induced a concentration- and time-dependent increase in cAMP, beginning at 1 nM; cAMP levels increased by 84-fold following 1 h exposure to 1 microM AF2. cGMP and IP(3) levels were unaffected by AF2 at concentrations

Subject(s)
Ascaris suum/metabolism , Cyclic AMP/metabolism , Neuromuscular Junction/metabolism , Neuropeptides/pharmacology , Animals , Ascaris suum/drug effects , Cyclic GMP/metabolism , Female , In Vitro Techniques , Inositol 1,4,5-Trisphosphate/metabolism , Muscle Contraction/drug effects , Neuromuscular Junction/drug effects , Stimulation, Chemical
3.
Bioorg Med Chem Lett ; 9(12): 1727-32, 1999 Jun 21.
Article in English | MEDLINE | ID: mdl-10397509

ABSTRACT

Following our discovery of the strong binding of thiadiazole 1 to the AF-2 neuropeptide receptor of gastrointestinal nematodes (e.g., Ascaris suum), we prepared two series of analogs. Only the series containing the thiadiazole ring had potencies comparable to that of compound 1. Analog 50 exhibited an apparent potency in the AF-2 binding assay 300 times that of compound 1.


Subject(s)
Anthelmintics/chemical synthesis , Helminth Proteins/metabolism , Neuropeptides/metabolism , Thiadiazoles/chemical synthesis , Animals , Anthelmintics/chemistry , Anthelmintics/pharmacology , Ascaris suum , Caenorhabditis elegans/drug effects , Caenorhabditis elegans/physiology , Helminth Proteins/drug effects , Neuropeptides/drug effects , Structure-Activity Relationship , Thiadiazoles/chemistry , Thiadiazoles/pharmacology
4.
Ann N Y Acad Sci ; 897: 212-27, 1999.
Article in English | MEDLINE | ID: mdl-10676450

ABSTRACT

Nervous systems of helminths are highly peptidergic. Species in the phylum Nematoda (roundworms) possess at least 50 FMRFamide-related peptides (FaRPs), with more yet to be identified. To date, few non-FaRP neuropeptides have been identified in these organisms, though evidence suggests that other families are present. FaRPergic systems have important functions in nematode neuromuscular control. In contrast, species in the phylum Platyhelminthes (flatworms) apparently utilize fewer FaRPs than do nematodes; those species examined possess one or two FaRPs. Other neuropeptides, such as neuropeptide F (NPF), play key roles in flatworm physiology. Although progress has been made in the characterization of FaRP pharmacology in helminths, much remains to be learned. Most studies on nematodes have been done with Ascaris suum because of its large size. However, thanks to the Caenorhabditis elegans genome project, we know most about the FaRP complement of this free-living animal. That essentially all C. elegans FaRPs are active on at least one A. suum neuromuscular system argues for conservation of ligand-receptor recognition features among the Nematoda. Structure-activity studies on nematode FaRPs have revealed that structure-activity relationship (SAR) "rules" differ considerably among the FaRPs. Second messenger studies, along with experiments on ionic dependence and anatomical requirements for activity, reveal that FaRPs act through many different mechanisms. Platyhelminth FaRPs are myoexcitatory, and no evidence exists of multiple FaRP receptors in flatworms. Interestingly, there are examples of cross-phylum activity, with some nematode FaRPs being active on flatworm muscle. The extent to which other invertebrate FaRPs show cross-phylum activity remains to be determined. How FaRPergic nerves contribute to the control of behavior in helminths, and are integrated with non-neuropeptidergic systems, also remains to be elucidated.


Subject(s)
FMRFamide/analogs & derivatives , FMRFamide/pharmacology , Helminths/physiology , Amino Acid Sequence , Animals , FMRFamide/physiology , Helminths/drug effects , Nematoda/drug effects , Nematoda/physiology , Signal Transduction
5.
Parasitol Today ; 12(9): 351-7, 1996 Sep.
Article in English | MEDLINE | ID: mdl-15275173

ABSTRACT

FMRFamide-related peptides (FaRPs) are the largest known family of invertebrate neuropeptides. Immunocytochemical screens of nematode tissues using antisera raised to these peptides have localized extensive FaRP-immunostaining to their nervous systems. Although 21 FaRPs have been isolated and sequenced from extracts of free-living and parasitic nematodes, available evidence indicates that other FaRPs await discovery. While our knowledge of the pharmacology of these native nematode neuropeptides is extremely limited, reports on their physiological activity in nematodes are ever increasing. All the nematode FaRPs examined so far have been found to have potent and varied actions on nematode neuromuscular activity. It is only through the extensive pharmacological and physiological assessment of the tissue, cell and receptor interactions of these peptidic messengers that an understanding of their activity on nematode neuromusculature will be possible. In this review, Aaron Maule and colleagues examine the current understanding of the pharmacology of nematode FaRPs.

6.
Int J Parasitol ; 26(8-9): 927-36, 1996.
Article in English | MEDLINE | ID: mdl-8923140

ABSTRACT

The application of rational (mechanism-based) approaches to anthelmintic discovery requires information about target proteins which are pharmacologically distinguishable from their vertebrate homologs. In helminths, several such targets (e.g., beta-tubulin, ATP-generating enzymes, cholinergic receptors, CI- channels) have been characterized only after the discovery, through empirical screening, of compounds that interfere with their function. From the perspective of anthelmintic discovery, the utility of these targets is diminishing due to the emergence of drug-resistant strains of parasites. This has motivated the search for compounds with novel modes-of-action. Recent basic research in helminth physiology and biochemistry has identified several potential targets for rational anthelmintic discovery, including receptors for FMRFamide-related peptides (FaRPs). To date, over 20 different nematode FaRPs have been identified and these peptides, which are broadly distributed in helminths, have been localized to all of the major neuronal subtypes in nematodes. The FaRPs that have been examined have been found profoundly to affect somatic muscle function in gastrointestinal nematodes. In this respect, complex inhibitory and excitatory actions have been identified for a number of these peptides. Although the transduction pathways for any of these peptides remain to be elucidated, the available evidence indicates that nematode FaRPs have numerous mechanisms of action. The employment of nematode neuropeptide receptors in mechanism-based screens has immense potential in the identification of novel anthelmintics.


Subject(s)
Invertebrate Hormones/analysis , Nematoda/chemistry , Neuropeptides/analysis , Amino Acid Sequence , Animals , FMRFamide , Invertebrate Hormones/chemistry , Invertebrate Hormones/physiology , Neuropeptides/chemistry , Neuropeptides/physiology
7.
Peptides ; 17(3): 381-7, 1996.
Article in English | MEDLINE | ID: mdl-8735963

ABSTRACT

Analogues of KNEFIRFamide (Lys-Asn-Glu-Phe-Ile-Arg-Phe-NH2; AF1), an FMRFamide-related peptide (FaRP) originally isolated from Ascaris suum, were characterized in an A. suum muscle tension assay. AF1 had biphasic effects on this preparation, inducing a brief relaxation followed by excitation and spastic paralysis. Activity of AF1 in this assay was eliminated by N-terminal deletions and by deamidation of the carboxy-terminus. The potency of AF1 was greatly reduced by alanine substitution for any residue. Peptides that retained activity did not show the biphasic response observed with AF1, suggesting that the inhibitory and excitatory phases seen with AF1 may be due to activation of distinct receptors. The basis for the marked differences in potency observed between AF1 and the structurally related nematode FaRP, AF2 (KHEYLRFamide) was also tested. AF2 is approximately 1000-fold more potent than AF1 in this assay, but has physiological effects that are otherwise indistinguishable. KNEYIRFamide and KNEFLRFamide induced characteristic AF1/AF2 responses, but were much less potent than the native peptides. In contrast, KHEYIRFamide resembled AF1 in potency and pattern of responses. These data suggest that AF1 and AF2 act at distinct receptors, and hypothesis supported by the observation that KNEFIAFamide antagonized the effects of AF1 but not of AF2.


Subject(s)
Muscle Contraction/drug effects , Muscles/drug effects , Neuropeptides/pharmacology , Alanine/chemistry , Alanine/pharmacology , Amino Acid Sequence , Animals , Ascaris suum , Dose-Response Relationship, Drug , Molecular Sequence Data , Neuropeptides/chemical synthesis , Structure-Activity Relationship , Time Factors
8.
Parasitology ; 113 Suppl: S119-35, 1996.
Article in English | MEDLINE | ID: mdl-9051931

ABSTRACT

The occurrence of classical neurotransmitter molecules and numerous peptidic messenger molecules in nematode nervous systems indicate that although structurally simple, nematode nervous systems are chemically complex. Thus far, studies on one nematode neuropeptide family, namely the FMRFamide-related peptides (FaRPs), have revealed an unexpected variety of neuropeptide structures in both free-living and parasitic species. To date 23 nematode FaRPs have been structurally characterized including 12 from Ascaris suum, 8 from Caenorhabditis elegans, 5 from Panagrellus redivivus and 1 from Haemonchus contortus. Ten FaRP-encoding genes have been identified in Caenorhabditis elegans. However, the full complement of nematode neuronal messengers has yet to be described and unidentified nematode FaRPs await detection. Preliminary characterization of the actions of nematode neuropeptides on the somatic musculature and neurones of A, suum has revealed that these peptidic messengers have potent and complex effects. Identified complexities include the biphasic effects of KNEFIRFamide/KHEYLRFamide (AF1/2; relaxation of tone followed by oscillatory contractile activity) and KPNFIRFamide (PF4; rapid relaxation of tone followed by an increase in tone), the diverse actions of KSAYMRFamide (AF8 or PF3; relaxes dorsal muscles and contracts ventral muscles) and the apparent coupling of the relaxatory effects of SDPNFLRFamide/SADPNFLRFamide (PF1/PF2) to nitric oxide release. Indeed, all of the nematode FaRPs which have been tested on somatic muscle strips of A. suum have actions which are clearly physiologically distinguishable. Although we are a very long way from understanding how the actions of these peptides are co-ordinated, not only with those of each other but also with those of the classical transmitter molecules, to control nematode behaviour, their abundance coupled with their diversity of structure and function indicates a hitherto unidentified sophistication to nematode neuromuscular intergration.


Subject(s)
Nematoda/physiology , Neuromuscular Agents , Neuropeptides/physiology , Neurotransmitter Agents/physiology , Animals , FMRFamide , Forecasting , Nematoda/metabolism , Neuropeptides/genetics , Neuropeptides/metabolism , Neurotransmitter Agents/genetics , Neurotransmitter Agents/metabolism
9.
Invert Neurosci ; 1(3): 255-65, 1995 Dec.
Article in English | MEDLINE | ID: mdl-9372147

ABSTRACT

A large number of FMRFamide-related peptides (FaRPs) are found in nematodes, and some of these are known to influence tension and contractility of neuromuscular strips isolated from Ascaris suum body wall. Relaxation of these strips has been noted with five nematode FaRPs. The inhibitory actions of SDPNFLRFamide (PF1) and SADPNFLRFamide (PF2) appear to be mediated by nitric oxide, as previously demonstrated with inhibitors of nitric oxide synthase (NOS). This present study showed that the effects of PF1 were also depended on external Ca++ and were reduced by the Ca(++)-channel blocker verapamil, observations consistent with the finding that nematode NOS is Ca(++)-dependent. KSAYMRFamide (PF3), KNIRFamide (PF4) and KNAFIRFamide (an alanine substituted analog of KNEFIRFamide, AF1, termed A3AF1) also relaxed A. suum muscle strips, but these responses were not affected by NOS inhibitors. PF3 inhibited the activity of strips prepared from the dorsal side of the worm, but contracted ventral strips. Both effects were dependent on the presence of ventral/dorsal nerve cords (unlike PF1/PF2) and were attenuated in medium which contained high K+ or low Ca++. PF4-induced muscle relaxation and hyperpolarization were independent of nerve cords, but were reversed in Cl-free medium, unlike PF1 or PF3. The PF4 effect physiologically desensitized muscle strips to subsequent treatment with PF4 and/or GABA. However, PF4 and GABA were not synergistic in this preparation. The effects of GABA, but not PF4, were reduced in muscle strips treated with the GABA antagonist, NCS 281-93. Following PF4 (or GABA) relaxation, subsequent treatment with higher doses of PF4 caused muscle strip contraction. A3AF1 was found to relax muscle strips and hyperpolarize muscle cells independently of the ventral and dorsal nerve cords, K+, Ca++, and Cl-, and mimicked the inhibitory phase associated with the exposure of these strips to AF1. On the basis of anatomical and ionic dependence, these data have delineated at least four distinct inhibitory activities attributable to nematode FaRPs. Clearly, a remarkably complex set of inhibitory mechanisms operate in the nematode neuromuscular system.


Subject(s)
Ascaris suum/physiology , FMRFamide/pharmacology , Muscles/drug effects , Peptide Fragments/physiology , Animals , Female , In Vitro Techniques , Isotonic Solutions/pharmacology , Membrane Potentials/drug effects , Muscle Contraction/physiology , Muscles/physiology , Oligopeptides/pharmacology , gamma-Aminobutyric Acid/pharmacology
10.
Int J Parasitol ; 25(11): 1273-80, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8635879

ABSTRACT

The chemotherapeutic control of helminth parasites is compromised by the limited number of classes of anthelmintic drugs. Discovery of novel anthelmintics is impeded by the lack of novel screening technologies that overcome the difficulties inherent in screens based on whole organism toxicity. The development and implementation of mechanism-based screens for new anthelmintics offers great promise for the revitalization of antiparasitic drug discovery. However, mechanism-based screens must be based on a thorough understanding of the proteins or processes that offer the best chance for selective chemotherapeutic intervention. Basic research on the characterization of nematode FMRFamide-related peptides (FaRPs) has revealed that these peptides are ubiquitously distributed in helminths. Chemical identification of a number of nematode FaRPs has been achieved, and these peptides have potent and profound effects on the nematode neuromuscular system. Physiological processes mediated by nematode FaRPs (and other helminth neuropeptides) offer potential targets for the discovery of novel anthelmintics.


Subject(s)
Anthelmintics/chemical synthesis , Helminthiasis/drug therapy , Nematoda/physiology , Neuropeptides/physiology , Amino Acid Sequence , Animals , Drug Design , FMRFamide , Humans , Molecular Sequence Data , Nematoda/drug effects , Neuropeptides/chemistry , Neuropeptides/isolation & purification , Structure-Activity Relationship
11.
J Neurophysiol ; 74(5): 1880-8, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8592181

ABSTRACT

1. The physiological effects of two Phe-Met-Arg-Phe-NH2 (FMRFamide)-related neuropeptides isolated from the free-living nematode Panagrellus redivivus, SDPNFLRFamide (PF1) and SADPNFLRFamide (PF2), were examined using neuromuscular preparations from the parasitic nematode Ascaris suum. 2. PF1 and PF2 hyperpolarized muscle membrane and induced sustained flaccid paralysis, independent of external Cl-, in both innervated and denervated preparations. 3. PF1 reversed spastic contractions induced by the cholinomimetic levamisole, elevated K+, or the excitatory nematode FMRFamide-related neuropeptides KNEFIRFamide or KHEYLRFamide. 4. PF1 reversal of levamisole contraction was blocked by pretreatment with agents that interfere with nitric oxide (NO) synthesis (e.g., N-nitro-L-arginine), whereas sodium nitroprusside, which releases NO in solution, mimicked PF1 and PF2. 5. NO synthase activity, monitored by the conversion of [3H]arginine to [3H]citrulline, was twice as abundant in A. suum hypodermis as in muscle, but was not present in reproductive tissue. The relative abundance of NO synthase activity in these tissues was similar to the observed specific binding of [3H]PF1. 6. These results suggest that the inhibitory effects of PF1 and PF2 on nematode somatic muscle are mediated by NO, and that the hypodermis may serve a role in this process analogous to that of the endothelium in vertebrate vasculature.


Subject(s)
Ascaris suum/physiology , FMRFamide , Helminth Proteins/physiology , Neuropeptides/physiology , Amino Acid Sequence , Animals , Chlorides/pharmacology , Culture Media , Female , In Vitro Techniques , Membrane Potentials/drug effects , Membrane Potentials/physiology , Molecular Sequence Data , Muscle Denervation , Muscle Relaxation/drug effects , Muscle Relaxation/physiology , Nitric Oxide/physiology , Paralysis/physiopathology , Radioligand Assay
12.
Peptides ; 16(1): 87-93, 1995.
Article in English | MEDLINE | ID: mdl-7716079

ABSTRACT

A novel FMRFamide-related heptapeptide, Lys-Pro-Asn-Phe-Ile-Arg-Phe-NH2 (KPNFIRFamide), was isolated and characterized from acid ethanol extracts of the free-living nematode, Panagrellus redivivus. Whole-worm extracts contained > or = 9 pmol KPNFIRFamide/g wet weight. A synthetic replicate of this peptide induced a rapid relaxation of tone and inhibited spontaneous contractility in isolated innervated and denervated body-wall muscle strips of the parasitic nematode, Ascaris suum. KPNFIRFamide (0.1 nM) induced measurable relaxations in 50% of the muscle preparations examined. Concentrations > or = 0.3 nM induced relaxation in 100% of muscle preparations examined. The relaxation was short-lived at concentrations of peptide > or = 1 microM and displayed a profile typical of receptor desensitization. These data suggest the occurrence of a closely related peptide in A. suum and add further evidence to the concept of primary structural conservation of FaRPs within the nematodes.


Subject(s)
Neurotransmitter Agents/isolation & purification , Oligopeptides/chemistry , Oligopeptides/physiology , Rhabditida/chemistry , Amino Acid Sequence , Animals , FMRFamide , Molecular Sequence Data , Muscles/drug effects , Muscles/physiology , Neuropeptides/chemistry , Neuropeptides/classification , Neurotransmitter Agents/physiology , Oligopeptides/pharmacology , Rhabditida/physiology
13.
Parasitology ; 109 ( Pt 3): 351-6, 1994 Sep.
Article in English | MEDLINE | ID: mdl-7970891

ABSTRACT

Available primary structural information suggests that the FMRFamide-related peptides (FaRPs) from parasitic and free-living nematodes are different, and that free-living forms may not represent appropriate models for the study of the neurochemistry of parasitic forms in the laboratory. However, here we report the isolation and unequivocal identification of AF2 (originally isolated from the parasite, Ascaris suum) from acidified alcoholic extracts of the free-living species, Panagrellus redivivus. While reverse-phase HPLC analysis of extracts revealed FMRFamide-immunoreactivity to be highly heterogeneous, AF2 was the predominant FMRFamide-immunoreactive peptide present (at least 26 pmol/g wet weight of worms). This peptide was also the major immunoreactant identified by an antiserum raised to the conserved C-terminal hexapeptide amide of mammalian pancreatic polypeptide (PP), which has been used previously to isolate neuropeptide F (NPF). These observations were confirmed by radioimmunoassay and chromatographic fractionation of an acidified alcoholic extract of A. suum heads. The FMRFamide-related peptides present in a nematode extract may be highly dependent on the extraction medium employed, and these data would suggest that this complement of neuropeptides may not be as different between parasitic and free-living nematodes as initial studies have suggested. Finally, all of the evidence suggests that NPF is not present in nematodes and that the PP-immunoreactant previously demonstrated immunochemically is probably AF2.


Subject(s)
Neuropeptides/isolation & purification , Rhabditida/chemistry , Amino Acid Sequence , Animals , Chromatography, High Pressure Liquid , Cross Reactions , Molecular Sequence Data , Neuropeptides/chemistry , Neuropeptides/immunology , Pancreatic Polypeptide/immunology , Peptide Fragments/immunology , Radioimmunoassay , Sequence Analysis , Tissue Extracts
14.
Biochem Biophys Res Commun ; 200(2): 973-80, 1994 Apr 29.
Article in English | MEDLINE | ID: mdl-8179635

ABSTRACT

In nematodes, FMRFamide-related peptides (FaRPs) have been structurally characterised from the parasite, Ascaris suum, and from two free-living species, Panagrellus redivivus and Caenorhabditis elegans. While both FaRPs isolated from P. redivivus (PF1 and PF2) have been identified in C. elegans, the two heptapeptides isolated from A. suum (AF1 and AF2) have until recently been considered unique to this parasitic species. We have recently isolated AF2 from P. redivivus and, during this study, an additional novel heptapeptide amide, Lys-Ser-Ala-Tyr-Met-Arg-Phe amide (KSAYMRFamide), was structurally characterised. A synthetic replicate of this peptide induced a rapid concentration-dependent muscle tension increase in an isolated. A. suum somatic muscle preparation, with a threshold of approximately 0.1 microM. These data suggest that the complement of FaRPs in parasitic and free-living nematodes may not be as radically different as preliminary studies would suggest, and that the absence of AF1, AF2 and KSAYMRFamide on the C.elegans FMRFamide-related peptide gene (flp-1) may imply the presence of at least two different FaRP genes in nematodes.


Subject(s)
Ascaris suum/drug effects , Helminth Proteins/metabolism , Neuropeptides/physiology , Rhabditida/physiology , Amino Acid Sequence , Animals , Ascaris suum/genetics , Ascaris suum/physiology , FMRFamide , Genes, Helminth , Helminth Proteins/genetics , Helminth Proteins/pharmacology , Molecular Sequence Data , Muscle Contraction/drug effects , Neuropeptides/genetics , Neuropeptides/pharmacology , Rhabditida/genetics
15.
J Parasitol ; 78(2): 215-30, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1556638

ABSTRACT

Processes that critically differentiate parasitic helminths and their hosts are obvious candidates for chemotherapeutic intervention. The recognition that neurobiology distinguishes helminths from their vertebrate hosts is due in part to the fact that several efficacious anthelmintics, derived generally from empirical screening, have been found to act selectively on the neuromuscular system of these parasites. In addition, basic physiological and pharmacological research has revealed considerable differences in the ways in which helminths and their hosts transmit information in the nervous system and respond to it in innervated tissues. Unfortunately, most of these differences have yet to be exploited in chemotherapy. The topics for this review include an analysis of mechanistic aspects of the pharmacology of anthelmintics that act on neuromuscular systems and a consideration of the prospects for discovery of novel drugs that act on this system.


Subject(s)
Anthelmintics/pharmacology , Helminthiasis/drug therapy , Helminths/drug effects , Animals , Anthelmintics/therapeutic use , Cestoda/drug effects , Nematoda/drug effects , Nervous System/drug effects , Trematoda/drug effects
16.
Peptides ; 13(2): 209-14, 1992.
Article in English | MEDLINE | ID: mdl-1408999

ABSTRACT

Peptides of the FXRFamide family, where X = M, I or L, are broadly distributed among invertebrates. Two such peptides were purified and sequenced from the free-living nematode, Panagrellus redivivus. Immunohistochemical techniques localized FMRFamide-like material in several regions of these organisms, including the nerve cords and, most prominently, in paired groups of cells located caudally to the base of the pharynx. RIA determinations gave an estimate of 2.8 nmol immunoreactive peptide/g of an acetone extract of P. redivivus. Four sequential HPLC purification steps, followed by sequencing by automated Edman degradation and FAB-MS, led to the identification of Ser-Asp-Pro-Asn-Phe-Leu-Arg-Phe-amide (SDPNFLRFamide) and Ser-Ala-Asp-Pro-Asn-Phe-Leu-Arg-Phe-amide (SADPNFLRFamide) as members of the FXRFamide family in this nematode.


Subject(s)
Helminth Proteins/isolation & purification , Invertebrate Hormones/isolation & purification , Nematoda/chemistry , Neuropeptides/isolation & purification , Amino Acid Sequence , Animals , FMRFamide , Helminth Proteins/chemistry , Helminth Proteins/immunology , Immunohistochemistry , Invertebrate Hormones/chemistry , Invertebrate Hormones/immunology , Molecular Sequence Data , Nerve Tissue/chemistry , Neuropeptides/chemistry , Neuropeptides/immunology
17.
Article in English | MEDLINE | ID: mdl-1685403

ABSTRACT

1. Dihydroavermectin B1a (DHAVM, Ivermectin) at 1 microM reduces excitatory and inhibitory postsynaptic potentials (EPSPs and IPSPs, respectively) in stretcher muscle fibres of the lined shore crab, Pachygrapsus crassipes. IPSPs decline faster and more extensively than EPSPs and, unlike EPSPs, do not recover upon replacement of DHAVM with picrotoxinin-containing medium. 2. Intracellular recordings show DHAVM reduces membrane resistance (Rin) and hyperpolarizes muscle fibres in a concentration-dependent manner, beginning at 10 nM. The rate and magnitude of DHAVM effects on Rin mirror its effects on EPSPs. 3. The decline in Rin due to DHAVM is sustained over time (i.e. there is no tendency for desensitization); it is also irreversible and not affected by coadministration of 1 mM gamma-aminobutyric acid (GABA), 0.1 mM bicuculline methiodide or addition of 20 mM Co2+ to the recording medium. 4. Replacement of DHAVM-containing medium with medium containing Cl- channel blockers (picrotoxinin or lindane) results in partial recovery of Rin, while channel blockers specific for other ions (TTX, TEA, 4-AP or verapamil) are without effect. The decline of Rin following application of DHAVM is attenuated in Cl(-)-free medium. 5. Results of tests using compounds structurally related to DHAVM reveal that relatively minor changes in the molecule often reduce biological activity significantly. Removal of one sugar, for instance, results in a ten-fold reduction in potency. 6. In general, avermectins that stimulate conductance in shore crab muscle also possess anthelmintic activity at similar concentrations, based on studies using the free-living nematode, Caenorhabditis elegans.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Brachyura/drug effects , Ivermectin/pharmacology , Muscles/drug effects , Animals , Anthelmintics/pharmacology , Bicuculline/analogs & derivatives , Bicuculline/pharmacology , Caenorhabditis/drug effects , Caenorhabditis/physiology , Chlorides/pharmacology , Cobalt/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , In Vitro Techniques , Ivermectin/analogs & derivatives , Membrane Potentials/drug effects , Membranes/drug effects , Membranes/physiology , Motor Endplate/drug effects , Motor Endplate/physiology , Muscimol/pharmacology , Muscles/innervation , Picrotoxin/analogs & derivatives , Picrotoxin/pharmacology , Sesterterpenes , Structure-Activity Relationship , Synapses/drug effects , Synapses/physiology , Time Factors , gamma-Aminobutyric Acid/pharmacology , gamma-Aminobutyric Acid/physiology
18.
JAMA ; 234(10): 1019, 1975 Dec 08.
Article in English | MEDLINE | ID: mdl-1242406
SELECTION OF CITATIONS
SEARCH DETAIL
...